IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Industrial Biotech

Displaying 121 - 140 of 166 stories.
April 22, 2010
A wave of start-up companies are bringing new bioprocessing technologies from the laboratory to the market and making collaborative deals with chemical companies and other players from...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Biochemicals-Start-ups-Pick-their-Partners-with-videos_25731.html
March 17, 2010
Brazilian trade officials say they are considering suspending patent and intellectual property rights on goods including agricultural chemicals, biotechnology products, and...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/U-S-Brazil-Trade-Rift-Threatens-Patents-on-Agchem-Biotech-Products_25458.html
March 16, 2010
CEO for NEPIC It is with great sadness that we heard of the death of Dr Ashok Kumar MP for Middlesbrough South & East Cleveland. He was well respected by his colleagues in the...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/A-Tribute-to-Ashok-Kumar-Member-of-U-K-s-Parliament-Chemical-Engineer-and-Industry-Supporter_25431.html
February 10, 2010
Some start-ups entering the biofuels sector already are revealing themselves as winners in certain market applications even though there is no shortage of mature biofuel companies...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Biofuels-Firms-Rated-New-Order-Emerges_24679.html
January 28, 2010
Fine chemicals group Lonza says its Ebitda for full year 2009 fell 4.8% to SF 658 million ($626 million) on corresponding sales down 8.4% to SF2.7 billion. The company says it...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Lonza-Struggles-in-the-Face-of-Lower-Demand-update_24402.html
January 22, 2010
Bioengineer Trygve Brautaset, a researcher at Sintef Group (Trondheim, Norway), Scandinavia’s largest independent research organisation, has been awarded NK11 million ($1.9...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Scandinavia-to-Develop-a-Lysine-from-Methanol-Process_24305.html
January 21, 2010
Bioamber (Pomacle, France), a three year old joint venture between DNP Green Technology (Princeton, NJ) and (Agro-industrie Recherches et Développements (ARD; Pomacle), an...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Start-up-Commissions-First-Commercial-Biosuccinic-Acid-Plant_24232.html
December 9, 2009
A group of 25 companies from France and Brazil, including Rhodia, have made a joint commitment to develop industrial partnerships aimed at reducing emissions of greenhouse gases (GHG)...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/French-and-Brazilian-Firms-Collaborate-to-Cut-Greenhouse-Gas-Emissions_23361.html
October 26, 2009
Merck KGaA says its Pharma Raw Materials unit is expanding its activities and has divided the business, earlier this month, into two divisions; biopharma tools, and classical pharma...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/CPhI-Merck-KGaA-to-Add-Pharma-Production-Capacity-Mulls-China-Facility_22137.html
October 22, 2009
Lonza says it has signed an investment agreement, including a right of first refusal for the commercial production of products, with innovative biotechnology company Cilian...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Lonza-to-Acquire-Stake-in-German-Biotech-Firm_22240.html
October 2, 2009
Sanofi-Aventis (Paris) says it has entered into an exclusive global collaboration and licensing agreement with biotechnology company Merrimack Pharmaceuticals (Cambridge, MA) for...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Sanofi-Aventis-Signs-Licensing-Agreement-with-U-S-Biotech-Firm_21788.html
September 14, 2009
Biopharmaceutical company Amylin Pharmaceuticals (San Diego, CA) and biotechnology firm Biocon (Bangalore, India) say they have entered into an exclusive agreement to jointly develop...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Biocon-Amylin-Pharmaceuticals-in-Deal-for-Peptide-Hybrid_21331.html
August 27, 2009
Pfizer says it has opened a previously announced new facility for biotechnological pharmaceutical production at Strangnas, Sweden. Pfizer expects the plant, which was built with an...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Pfizer-Opens-Biotech-Plant-in-Sweden_21052.html
July 23, 2009
Sigma-Aldrich reported second-quarter earnings of 68 cts/share, compared to 70 cts/share in the year-ago period. The company's earnings for the first six months of 2009 totaled...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Sigma-Aldrichs-Earnings-Decline_20335.html
June 26, 2009
Lonza says it has signed a deal to produce therapeutic monoclonal antibody Anthim for biopharmaceutical company Elusys Therapeutics (Pine Brook, NJ). Anthim, which is in late-stage...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Lonza-Signs-Manufacturing-Deal-with-Biopharma-Firm_19832.html
June 15, 2009
The global market for fermentation ingredients is set to grow at a compound annual growth rate (CAGR) of 7%, leading to sales of $22.3 billion by the end of 2013, according to a report...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Fermentation-Ingredients-Market-Set-to-Hit-$22-3-Billionyear-by-2014-update_19567.html
June 2, 2009
DSM says it has entered into an agreement to acquire privately held biotechnology company Biopract (Berlin). Financial details of the deal were not disclosed. The acquisition of...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/DSM-Acquires-German-Biotech-Firm_19321.html
April 22, 2009
Venture capital investment in U.S. Biotech firms during the first quarter of the year fell 47%, compared with the year-ago period, to $3 billion, according to a report by...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Venture-Capital-Investment-in-U-S-Biotech-Hits-12-year-Low_18396.html
April 20, 2009
Microbia (Lexington, MA), a specialty chemicals company developing two carotenoid products, expects to commercialize its first two products by the end of 2010. The company recently...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Microbia-Preparing-for-Commercialization_18361.html
Pages: « Previous  1 2 3 4 5 6 [7] 8 9 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa